HomeAVDL • NASDAQ
add
Avadel Pharmaceuticals PLC
Previous close
$21.34
Day range
$21.30 - $21.36
Year range
$6.38 - $23.57
Market cap
2.09B USD
Avg Volume
2.65M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 77.47M | 54.86% |
Operating expense | 79.65M | 80.21% |
Net income | 20.00K | 100.76% |
Net profit margin | 0.03 | 100.57% |
Earnings per share | 0.00 | 100.00% |
EBITDA | 3.05M | 331.07% |
Effective tax rate | 62.96% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 91.58M | 39.16% |
Total assets | 199.45M | 26.03% |
Total liabilities | 101.22M | 21.09% |
Total equity | 98.22M | — |
Shares outstanding | 97.66M | — |
Price to book | 21.13 | — |
Return on assets | 2.50% | — |
Return on capital | 3.66% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 20.00K | 100.76% |
Cash from operations | 22.20M | 422.28% |
Cash from investing | -8.43M | -271.05% |
Cash from financing | 2.51M | 113.00% |
Net change in cash | 16.41M | 6,292.83% |
Free cash flow | -11.88M | -18.87% |
About
Founded
2015
Website
Employees
188
